Publication:
Neuropathic Pain in a Large Turkish Family with Fabry Disease

Simple item page
dc.contributor.authorTurker, H.
dc.contributor.authorAkpinar, K.
dc.contributor.authorCengiz, K.
dc.contributor.authorBayrak, A. O.
dc.contributor.authorOgur, G.
dc.date.accessioned2020-06-21T14:16:30Z
dc.date.available2020-06-21T14:16:30Z
dc.date.issued2013
dc.departmentOMÜen_US
dc.department-temp[Turker, H. -- Akpinar, K. -- Bayrak, A. O.] Ondokuz Mayis Univ, Sch Med, Dept Neurol, Samsun, Turkey -- [Cengiz, K.] Ondokuz Mayis Univ, Sch Med, Dept Nephrol, Samsun, Turkey -- [Ogur, G.] Ondokuz Mayis Univ, Sch Med, Dept Med Genet, Samsun, Turkey --en_US
dc.description4th International Congress on Neuropathic Pain -- MAY 23-26, 2013 -- Toronto, CANADAen_US
dc.description.abstractFabry Disease is an X-linked lysosomal storage disease caused by the mutations in the GLA gene coding for the lysosomal enzyme alpha-galactosidase in chromosome Xq22.1. Neuropathic pain is common. In this study, our goal was to investigate the diagnostic yield of Lanss and DN4 scores which have not been used in Fabry Disease until now, to our knowledge. We also kept track of these tests in the followup. The pain scores before and after each and every two months of ERT (the patients received ERT every two weeks) regressed during ten months of therapy and this regression was statistically significant (p=0.001).en_US
dc.identifier.endpage76en_US
dc.identifier.isbn9788875876883
dc.identifier.startpage73en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/16036
dc.identifier.wosWOS:000334913700017
dc.language.isoenen_US
dc.publisherMedimond SRLen_US
dc.relation.journal4Th International Congress on Neuropathic Painen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleNeuropathic Pain in a Large Turkish Family with Fabry Diseaseen_US
dc.typeConference Objecten_US
dspace.entity.typePublication

Files

Collections

WoS İndeksli Yayınlar Koleksiyonu